Atlas Trials

Study of Sivelestat Sodium Hydrate in Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS) in Japan

Clinical trial NCT00219375 · COMPLETED

Trial details

NCT number
NCT00219375
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Lung InjurySystemic Inflammatory Response Syndrome
Start date
2004-06-01
Primary completion
2007-07-01
Enrollment
649

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.